• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Transbound Emerg Dis . In vitro Characterisation of SARS-CoV-2 and Susceptibility of Domestic Ferrets (Mustela putorius furo)

tetano

Editor, Senior Moderator
Transbound Emerg Dis


. 2021 Jan 5.
doi: 10.1111/tbed.13978. Online ahead of print.
In vitro Characterisation of SARS-CoV-2 and Susceptibility of Domestic Ferrets (Mustela putorius furo)


Glenn A Marsh[SUP] 1 [/SUP], Alexander J McAuley[SUP] 1 [/SUP], Sheree Brown[SUP] 1 [/SUP], Elizabeth A Pharo[SUP] 1 [/SUP], Sandra Crameri[SUP] 1 [/SUP], Gough G Au[SUP] 1 [/SUP], Michelle L Baker[SUP] 1 [/SUP], Jennifer Barr[SUP] 1 [/SUP], Jemma Bergfeld[SUP] 1 [/SUP], Matthew Bruce[SUP] 1 [/SUP], Kathie Burkett[SUP] 1 [/SUP], Peter A Durr[SUP] 1 [/SUP], Clare Holmes[SUP] 1 [/SUP], Leonard Izzard[SUP] 1 [/SUP], Rachel Layton[SUP] 1 [/SUP], Suzanne Lowther[SUP] 1 [/SUP], Matthew J Neave[SUP] 1 [/SUP], Timothy Poole[SUP] 1 [/SUP], Sarah Riddell[SUP] 1 [/SUP], Brenton Rowe[SUP] 1 [/SUP], Elisha Soldani[SUP] 1 [/SUP], Vittoria Stevens[SUP] 1 [/SUP], Willy Suen[SUP] 1 [/SUP], Vinod Sundaramoorthy[SUP] 1 [/SUP], Mary Tachedjian[SUP] 1 [/SUP], Shawn Todd[SUP] 1 [/SUP], Lee Trinidad[SUP] 1 [/SUP], Sin?ad M Williams[SUP] 1 [/SUP], Julian D Druce[SUP] 2 [/SUP], Trevor W Drew[SUP] 1 [/SUP], S S Vasan[SUP] 1 3 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an emerging virus that has caused significant human morbidity and mortality since its detection in late 2019. With the rapid emergence has come an unprecedented programme of vaccine development with at least 300 candidates under development. Ferrets have proven to be an appropriate animal model for testing safety and efficacy of SARS-CoV-2 vaccines due to quantifiable virus shedding in nasal washes and oral swabs. Here we outline our efforts early in the SARS-CoV-2 outbreak to propagate and characterise an Australian isolate of the virus in vitro and in an ex vivo model of human airway epithelium, as well as to demonstrate the susceptibility of domestic ferrets (Mustela putorius furo) to SARS-CoV-2 infection following intranasal challenge.

Keywords: Animal Model; COVID-19; Coronavirus; Electron Microscopy; Ferrets; SARS-CoV-2.
 
Back
Top Bottom